Aster DM Healthcare Limited (NSE:ASTERDM)
India · Delayed Price · Currency is INR 730.35
-9.50 (-1.28%)
May 12, 2026, 3:30 PM IST
Aster DM Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 46,432 | 41,385 | 36,989 | 29,941 | 102,533 |
Other Revenue | 1,256 | - | - | - | - |
| 47,688 | 41,385 | 36,989 | 29,941 | 102,533 | |
Revenue Growth (YoY) | 15.23% | 11.88% | 23.54% | -70.80% | 19.11% |
Cost of Revenue | 19,244 | 18,466 | 17,231 | 14,352 | 65,858 |
Gross Profit | 28,444 | 22,919 | 19,759 | 15,588 | 36,674 |
Selling, General & Admin | 10,319 | 11,002 | 9,831 | 7,553 | 10,726 |
Other Operating Expenses | 7,859 | 4,262 | 4,146 | 3,545 | 11,103 |
Operating Expenses | 20,820 | 17,753 | 16,176 | 13,018 | 28,235 |
Operating Income | 7,624 | 5,167 | 3,582 | 2,570 | 8,439 |
Interest Expense | -1,230 | -1,076 | -1,061 | -851.5 | -2,551 |
Interest & Investment Income | - | 1,102 | 47.8 | 48.6 | 48 |
Earnings From Equity Investments | -370 | -189.1 | -113.4 | -112.2 | 5.4 |
Currency Exchange Gain (Loss) | - | -9.6 | -2.3 | - | -12.6 |
Other Non Operating Income (Expenses) | - | 133.4 | 156 | 296.2 | 429.4 |
EBT Excluding Unusual Items | 6,024 | 5,127 | 2,609 | 1,952 | 6,359 |
Merger & Restructuring Charges | - | -501.4 | - | - | - |
Gain (Loss) on Sale of Investments | - | 84.6 | 2.6 | 3.1 | 9.7 |
Other Unusual Items | -327.1 | - | - | - | - |
Pretax Income | 5,697 | 4,711 | 2,612 | 1,955 | 6,369 |
Income Tax Expense | 1,426 | 1,344 | 565.1 | 358.7 | 358 |
Earnings From Continuing Operations | 4,271 | 3,367 | 2,047 | 1,596 | 6,011 |
Earnings From Discontinued Operations | - | 50,712 | 68.8 | 3,159 | - |
Net Income to Company | 4,271 | 54,079 | 2,116 | 4,755 | 6,011 |
Minority Interest in Earnings | -389.6 | -300.6 | -822.8 | -505.8 | -750.6 |
Net Income | 3,881 | 53,778 | 1,293 | 4,249 | 5,260 |
Net Income to Common | 3,881 | 53,778 | 1,293 | 4,249 | 5,260 |
Net Income Growth | -92.78% | 4059.83% | -69.58% | -19.22% | 256.02% |
Shares Outstanding (Basic) | 515 | 498 | 498 | 497 | 497 |
Shares Outstanding (Diluted) | 516 | 499 | 498 | 498 | 498 |
Shares Change (YoY) | 3.52% | 0.12% | 0.02% | 0.02% | 0.02% |
EPS (Basic) | 7.53 | 107.99 | 2.60 | 8.54 | 10.58 |
EPS (Diluted) | 7.52 | 107.86 | 2.60 | 8.53 | 10.57 |
EPS Growth | -93.03% | 4050.66% | -69.54% | -19.30% | 255.89% |
Free Cash Flow | 1,868 | 790.1 | -6,391 | 11,171 | 8,310 |
Free Cash Flow Per Share | 3.62 | 1.58 | -12.83 | 22.44 | 16.69 |
Dividend Per Share | - | 5.000 | 2.000 | - | - |
Dividend Growth | - | 150.00% | - | - | - |
Gross Margin | 59.65% | 55.38% | 53.42% | 52.06% | 35.77% |
Operating Margin | 15.99% | 12.48% | 9.68% | 8.58% | 8.23% |
Profit Margin | 8.14% | 129.95% | 3.50% | 14.19% | 5.13% |
Free Cash Flow Margin | 3.92% | 1.91% | -17.28% | 37.31% | 8.11% |
EBITDA | 10,266 | 7,059 | 5,330 | 4,101 | 12,110 |
EBITDA Margin | 21.53% | 17.06% | 14.41% | 13.70% | 11.81% |
D&A For EBITDA | 2,643 | 1,893 | 1,747 | 1,531 | 3,671 |
EBIT | 7,624 | 5,167 | 3,582 | 2,570 | 8,439 |
EBIT Margin | 15.99% | 12.48% | 9.68% | 8.58% | 8.23% |
Effective Tax Rate | 25.03% | 28.52% | 21.64% | 18.35% | 5.62% |
Revenue as Reported | 47,688 | 42,867 | 37,238 | 30,310 | 103,039 |
Advertising Expenses | - | 1,192 | 1,028 | 781.5 | 1,373 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.